Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture

Cytotechnology

Volumn 36, Issue 1-3, 2001, Pages 117-123

  Franěk, František ^a   Strnad, Miroslav ^a   Havlíček, Libor ^a   Siglerová, Věra ^a   Fismolová, Ivana ^a   Eckschlager, Tomáš ^b  

^a INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cell cycle; Fed batch culture; Hybridoma; Purine derivatives; Semicontinuous culture

Indexed keywords

EID: 0035686186     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014020415912     Document Type: Conference Paper

References (26)

1. Activation of bovine oocytes by specific inhibition of cyclin-dependent kinases
2. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors
3. In vivo metabolism of 2,6,9-trisubstituted pufine- derived cyclin-dependent kinase inhibitor bohemine in mice: Glucosidation as the principal metabolic route
4. Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine
5. On-line monitoring of monoclonal antibody formation in high-density perfusion culture using FIA
6. Modulation of cell cycle progression and of antibody production in mouse hybridomas by a nucleotide analogue
7. Cell suicide in starving hybridoma culture: Survival-signal effect of some amino acids
8. Fragmented DNA and apoptotic bodies document the programmed way of cell death in hybridoma cultures
9. A novel cytostatic process enhances the productivity of Chinese hamster ovary cells
10. Synthetic cyclin-dependent kinase inhibitors. New generation of potent anti-cancer drugs
11. Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds
12. Isopolar phosphorus-modified nucleotide analogues
13. Regulation of cell growth by IRF-1 in BHK-21 cells
14. Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine
15. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon
16. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
17. Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors
18. Cyclin-dependent kinase inhibition by new C-alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex
19. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
20. Docking- based development of purine-like inhibitors of cyclin-dependent kinase-2
21. Cyclines and cyclin-dependent kinases: A biochemical view
22. Myoseverin, a microtubule-binding molecule with novel cellular effects
23. Enhanced antibody production at slowed growth rates: Experimental demonstration and a structured model
24. A simple structured model predicted positively-, negatively-, or non-growth associated antibody production rate depending on culture conditions
25. Growth rate suppression of cultured animal cells enhances protein productivity
26. Inhibition of cyclin-dependent kinases by purine analogues